BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 9779988)

  • 1. Rho family proteins and Ras transformation: the RHOad less traveled gets congested.
    Zohn IM; Campbell SL; Khosravi-Far R; Rossman KL; Der CJ
    Oncogene; 1998 Sep; 17(11 Reviews):1415-38. PubMed ID: 9779988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular functions of TC10, a Rho family GTPase: regulation of morphology, signal transduction and cell growth.
    Murphy GA; Solski PA; Jillian SA; Pérez de la Ossa P; D'Eustachio P; Der CJ; Rush MG
    Oncogene; 1999 Jul; 18(26):3831-45. PubMed ID: 10445846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible involvement of the inactivation of the Rho-Rho-kinase pathway in oncogenic Ras-induced transformation.
    Izawa I; Amano M; Chihara K; Yamamoto T; Kaibuchi K
    Oncogene; 1998 Dec; 17(22):2863-71. PubMed ID: 9879992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vav transformation requires activation of multiple GTPases and regulation of gene expression.
    Palmby TR; Abe K; Karnoub AE; Der CJ
    Mol Cancer Res; 2004 Dec; 2(12):702-11. PubMed ID: 15634759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effector domain mutants of Rho dissociate cytoskeletal changes from nuclear signaling and cellular transformation.
    Zohar M; Teramoto H; Katz BZ; Yamada KM; Gutkind JS
    Oncogene; 1998 Aug; 17(8):991-8. PubMed ID: 9747878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rho small G protein and cytoskeletal control.
    Takai Y; Kaibuchi K; Sasaki T; Tanaka K; Shirataki H; Nakanishi H
    Princess Takamatsu Symp; 1994; 24():338-50. PubMed ID: 8983086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guanine nucleotide exchange factors: activators of Ras superfamily proteins.
    Overbeck AF; Brtva TR; Cox AD; Graham SM; Huff SY; Khosravi-Far R; Quilliam LA; Solski PA; Der CJ
    Mol Reprod Dev; 1995 Dec; 42(4):468-76. PubMed ID: 8607978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signal transduction elements of TC21, an oncogenic member of the R-Ras subfamily of GTP-binding proteins.
    Movilla N; Crespo P; Bustelo XR
    Oncogene; 1999 Oct; 18(43):5860-9. PubMed ID: 10557073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. R-Ras is regulated by activators and effectors distinct from those that control Ras function.
    Huff SY; Quilliam LA; Cox AD; Der CJ
    Oncogene; 1997 Jan; 14(2):133-43. PubMed ID: 9010215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rho-regulated signals induce apoptosis in vitro and in vivo by a p53-independent, but Bcl2 dependent pathway.
    Esteve P; Embade N; Perona R; Jiménez B; del Peso L; León J; Arends M; Miki T; Lacal JC
    Oncogene; 1998 Oct; 17(14):1855-69. PubMed ID: 9778052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guanine nucleotide exchange factors: activators of the Ras superfamily of proteins.
    Quilliam LA; Khosravi-Far R; Huff SY; Der CJ
    Bioessays; 1995 May; 17(5):395-404. PubMed ID: 7786285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct expression patterns and transforming properties of multiple isoforms of Ost, an exchange factor for RhoA and Cdc42.
    Lorenzi MV; Castagnino P; Chen Q; Hori Y; Miki T
    Oncogene; 1999 Aug; 18(33):4742-55. PubMed ID: 10467422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical role of Rho in cell transformation by oncogenic Ras.
    Prendergast GC; Khosravi-Far R; Solski PA; Kurzawa H; Lebowitz PF; Der CJ
    Oncogene; 1995 Jun; 10(12):2289-96. PubMed ID: 7784077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catalysis of guanine nucleotide exchange on the CDC42Hs protein by the dbl oncogene product.
    Hart MJ; Eva A; Evans T; Aaronson SA; Cerione RA
    Nature; 1991 Nov; 354(6351):311-4. PubMed ID: 1956381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G proteins, phosphoinositides, and actin-cytoskeleton in the control of cancer growth.
    Maruta H; He H; Tikoo A; Vuong T; Nur-E-Kamal M
    Microsc Res Tech; 1999 Oct; 47(1):61-6. PubMed ID: 10506762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of small GTP binding proteins in the growth-promoting and antiapoptotic actions of gastrin.
    Stepan V; Ramamoorthy S; Pausawasdi N; Logsdon CD; Askari FK; Todisco A
    Am J Physiol Gastrointest Liver Physiol; 2004 Sep; 287(3):G715-25. PubMed ID: 15331357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
    Du J; Jiang B; Coffey RJ; Barnard J
    Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct involvement of cdc42 and RhoA GTPases in actin organization and cell shape in untransformed and Dbl oncogene transformed NIH3T3 cells.
    Olivo C; Vanni C; Mancini P; Silengo L; Torrisi MR; Tarone G; Defilippi P; Eva A
    Oncogene; 2000 Mar; 19(11):1428-36. PubMed ID: 10723134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical analyses of the Wrch atypical Rho family GTPases.
    Shutes A; Berzat AC; Chenette EJ; Cox AD; Der CJ
    Methods Enzymol; 2006; 406():11-26. PubMed ID: 16472646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.